KRMD Relative Valuation
KRMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, KRMD is overvalued; if below, it's undervalued.
Historical Valuation
KORU Medical Systems Inc (KRMD) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -32.51. The fair price of KORU Medical Systems Inc (KRMD) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：5.68
Fair
-454.40
PE
1Y
3Y
5Y
Trailing
Forward
123.92
EV/EBITDA
KORU Medical Systems Inc. (KRMD) has a current EV/EBITDA of 123.92. The 5-year average EV/EBITDA is 13.54. The thresholds are as follows: Strongly Undervalued below -299.17, Undervalued between -299.17 and -142.81, Fairly Valued between 169.89 and -142.81, Overvalued between 169.89 and 326.24, and Strongly Overvalued above 326.24. The current Forward EV/EBITDA of 123.92 falls within the Historic Trend Line -Fairly Valued range.
-109.13
EV/EBIT
KORU Medical Systems Inc. (KRMD) has a current EV/EBIT of -109.13. The 5-year average EV/EBIT is -23.33. The thresholds are as follows: Strongly Undervalued below -70.23, Undervalued between -70.23 and -46.78, Fairly Valued between 0.11 and -46.78, Overvalued between 0.11 and 23.56, and Strongly Overvalued above 23.56. The current Forward EV/EBIT of -109.13 falls within the Strongly Undervalued range.
5.77
PS
KORU Medical Systems Inc. (KRMD) has a current PS of 5.77. The 5-year average PS is 4.79. The thresholds are as follows: Strongly Undervalued below 1.33, Undervalued between 1.33 and 3.06, Fairly Valued between 6.53 and 3.06, Overvalued between 6.53 and 8.26, and Strongly Overvalued above 8.26. The current Forward PS of 5.77 falls within the Historic Trend Line -Fairly Valued range.
132.48
P/OCF
KORU Medical Systems Inc. (KRMD) has a current P/OCF of 132.48. The 5-year average P/OCF is 30.32. The thresholds are as follows: Strongly Undervalued below -174.59, Undervalued between -174.59 and -72.14, Fairly Valued between 132.77 and -72.14, Overvalued between 132.77 and 235.22, and Strongly Overvalued above 235.22. The current Forward P/OCF of 132.48 falls within the Historic Trend Line -Fairly Valued range.
220.80
P/FCF
KORU Medical Systems Inc. (KRMD) has a current P/FCF of 220.80. The 5-year average P/FCF is 4.21. The thresholds are as follows: Strongly Undervalued below -248.23, Undervalued between -248.23 and -122.01, Fairly Valued between 130.43 and -122.01, Overvalued between 130.43 and 256.65, and Strongly Overvalued above 256.65. The current Forward P/FCF of 220.80 falls within the Overvalued range.
KORU Medical Systems Inc (KRMD) has a current Price-to-Book (P/B) ratio of 15.96. Compared to its 3-year average P/B ratio of 6.92 , the current P/B ratio is approximately 130.68% higher. Relative to its 5-year average P/B ratio of 5.74, the current P/B ratio is about 177.96% higher. KORU Medical Systems Inc (KRMD) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -2.96%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -3.48% , the current FCF yield is about -100.00% lower.
15.96
P/B
Median3y
6.92
Median5y
5.74
-0.07
FCF Yield
Median3y
-2.96
Median5y
-3.48
Competitors Valuation Multiple
The average P/S ratio for KRMD's competitors is , providing a benchmark for relative valuation. KORU Medical Systems Inc Corp (KRMD) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 27.17%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of KRMD increased by 47.53% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -38.80 to -70.48.
The secondary factor is the Revenue Growth, contributed 27.17%to the performance.
Overall, the performance of KRMD in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is KORU Medical Systems Inc (KRMD) currently overvalued or undervalued?
What is KORU Medical Systems Inc (KRMD) fair value?
How does KRMD's valuation metrics compare to the industry average?
What is the current P/B ratio for KORU Medical Systems Inc (KRMD) as of Dec 05 2025?
What is the current FCF Yield for KORU Medical Systems Inc (KRMD) as of Dec 05 2025?
What is the current Forward P/E ratio for KORU Medical Systems Inc (KRMD) as of Dec 05 2025?